Abstract
The genetic make-up of an individual contributes to the susceptibility and response to viral infection. Although environmental, clinical and social factors have a role in the chance of exposure to SARS-CoV-2 and the severity of COVID-191,2, host genetics may also be important. Identifying host-specific genetic factors may reveal biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We formed a global network of researchers to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity. Here we describe the results of three genome-wide association meta-analyses that consist of up to 49,562 patients with COVID-19 from 46 studies across 19 countries. We report 13 genome-wide significant loci that are associated with SARS-CoV-2 infection or severe manifestations of COVID-19. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases3–7. They also represent potentially actionable mechanisms in response to infection. Mendelian randomization analyses support a causal role for smoking and body-mass index for severe COVID-19 although not for type II diabetes. The identification of novel host genetic factors associated with COVID-19 was made possible by the community of human genetics researchers coming together to prioritize the sharing of data, results, resources and analytical frameworks. This working model of international collaboration underscores what is possible for future genetic discoveries in emerging pandemics, or indeed for any complex human disease.
Original language | English |
---|---|
Pages (from-to) | 472-477 |
Number of pages | 6 |
Journal | Nature |
Volume | 600 |
Issue number | 7889 |
Early online date | 8 Jul 2021 |
DOIs | |
Publication status | Published - 8 Jul 2021 |
Bibliographical note
We thank the entire COVID-19 HGI community for their contributions and continued collaboration. The work of the contributing studies was supported by numerous grants from governmental and charitable bodies. Acknowledgements specific to contributing studies are provided in Supplementary Table 13. We thank G. Butler-Laporte, G. Wojcik, M.-G. Hollm-Delgado, C. Willer and G. Davey Smith for their extensive feedback and discussion.Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Mari E.K. Niemi, Juha Karjalainen, Rachel G. Liao, Benjamin M. Neale, Mark Daly, Andrea Ganna, Gita A. Pathak, Shea J. Andrews, Masahiro Kanai, Kumar Veerapen, Israel Fernandez-Cadenas, Eva C. Schulte, Pasquale Striano, Minttu Marttila, Camelia Minica, Eirini Marouli, Mohd Anisul Karim, Frank R. Wendt, Jeanne Savage, Laura Sloofman, 2023, vol. 621, issue 7977, p. E7-E26. Nature https://doi.org/10.1093/1476-4687
Data Availability Statement
Summary statistics generated by COVID-19 HGI are available at https://www.covid19hg.org/results/r5/ and are available on GWAS Catalog (study code GCST011074). The analyses described here utilize the freeze 5 data. COVID-19 HGI continues to regularly release new data freezes. Summary statistics for nonEuropean ancestry samples are not currently available due to the small individual sample sizes of these groups, but results for 13 loci lead variants are reported in Supplementary Table 3. Individual level data can be requested directly from contributing studies, listed in Supplementary Table 1. We used publicly available data from GTEx (https://gtexportal.org/home/), the Neale lab (http://www.nealelab.is/uk-biobank/), Finucane lab (https://www.finucanelab.org), FinnGen Freeze 4 cohort (https://www.finngen.fi/en/access_results), and eQTL catalogue release 3 (http://www.ebi.ac.uk/eqtl/).Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at https://doi.org/10.1038/s41586-021-03767-x.
Keywords
- Autoimmunity/genetics
- Body Mass Index
- COVID-19/genetics
- Critical Illness
- Female
- Genetic Loci/genetics
- Genetic Predisposition to Disease
- Genome-Wide Association Study
- Geographic Mapping
- Hospitalization
- Host-Pathogen Interactions/genetics
- Humans
- Inflammation/complications
- Information Dissemination
- Male
- Multifactorial Inheritance
- Racial Groups/genetics
- SARS-CoV-2/pathogenicity
- Smoking
Fingerprint
Dive into the research topics of 'Mapping the human genetic architecture of COVID-19'. Together they form a unique fingerprint.Datasets
-
Data from Mapping the human genetic architecture of COVID-19
Initiative, C. H. G. (Creator) & Griffin, J. (Creator), University of Aberdeen, 8 Jul 2021
DOI: 10.1038/s41586-021-03767, https://static-content.springer.com/esm/art%3A10.1038%2Fs41586-021-03767-x/MediaObjects/41586_2021_3767_MOESM1_ESM.pdf and 3 more links, https://static-content.springer.com/esm/art%3A10.1038%2Fs41586-021-03767-x/MediaObjects/41586_2021_3767_MOESM2_ESM.pdf, https://static-content.springer.com/esm/art%3A10.1038%2Fs41586-021-03767-x/MediaObjects/41586_2021_3767_MOESM4_ESM.pdf, https://static-content.springer.com/esm/art%3A10.1038%2Fs41586-021-03767-x/MediaObjects/41586_2021_3767_MOESM6_ESM.xlsx (show fewer)
Dataset